OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	28
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	23
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	20
Mesenchymal stromal cells: an update	18
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	18
Disparities in acute myeloid leukemia treatments and outcomes	18
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	17
Developmental regulation of primitive erythropoiesis	17
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	16
The impact of obesity-induced inflammation on clonal hematopoiesis	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	13
Humanized murine models of platelet function	13
Editorial introductions	13
Platelet lifespan and mechanisms for clearance	13
Multifaceted roles of CRISPR technology in blood cancer research	12
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	11
High-throughput genotyping tools for red blood cell antigens	10
Advances on the genetic basis of red cell membrane disorders	10
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Editorial introduction	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	9

Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	8
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Editorial introductions	7
Current Opinion in Hematology	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Modelling arterial thrombus formation in vitro	7
Editorial introductions	7
Translation defects in ribosomopathies	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
The state of prediction models in hematologic disease: a worrisome assessment	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
Chediak-Higashi syndrome	6
The immunology of PF4 polyanion interactions	6
Editorial introduction	6